SCHEMBL4541508

SCHEMBL4541508

CC(=O)Oc1cc(C(C)(C)C)ccc1C=NO

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
HPGD P15428 3/20 0.41
KDM4E B2RXH2 3/20 0.41
USP2 O75604 3/20 0.41
ALDH1A1 P00352 3/20 0.41
CYP2C19 P33261 2/20 0.41
HSD17B10 Q99714 1/20 0.41
BACE1 P56817 1/20 0.36
ALOX12 P18054 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
KMT2A Q03164 2/20 0.35
LMNA P02545 2/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
FGF23 Q9GZV9 1/20 0.35
CYP1A1 P04798 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4541504 0.86 MAPT (0.50) MAPTSMN1; SMN2HPGDKDM4EUSP2
SCHEMBL4541510 0.86 MAPT (0.50) MAPTSMN1; SMN2HPGDKDM4EUSP2
SCHEMBL4541506 0.79 CYP2C19 (0.57) MAPTSMN1; SMN2KDM4EUSP2CYP2C19
SCHEMBL17953132 0.77 KDM4E (0.55) HPGDKDM4EUSP2ALDH1A1CYP2C19
SCHEMBL22928144 0.76 CYP2C19 (0.49) SMN1; SMN2HPGDKDM4EUSP2ALDH1A1
SCHEMBL31251637 0.74 MAPT (0.62) MAPTSMN1; SMN2HPGDKDM4EALDH1A1
SCHEMBL28418778 0.74 ALDH1A1 (0.52) MAPTSMN1; SMN2HPGDKDM4EUSP2
SCHEMBL11599009 0.74 ACHE (0.56) HPGDKDM4EUSP2ALDH1A1CYP2C19
SCHEMBL11458014 0.74 KDM4E (0.41) MAPTSMN1; SMN2HPGDKDM4EUSP2
SCHEMBL12118572 0.73 TSHR (0.58) MAPTSMN1; SMN2HPGDKDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009081222-A1 SUBSTITUTED TRICYCLIC PYRIDINE OR PYRIMIDINE VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-02 WO disclosed